HomeProductsBioactive CompoundsEndocrine & Hormonal TargetsERREndoxifen
Chemical structure of CAS 112093-28-4

Endoxifen

CAS No.112093-28-4
MDL No.MFCD09840374
MFC25H27NO2
MW373.50
InChI KeyMHJBZVSGOZTKRH-IZHYLOQSSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

4-Hydroxy-N-desmethyltamoxifen is a stilbenoid.

CAS No.112093-28-4
Product NameEndoxifen

Associated Conditions

neoplasm·breast ductal carcinoma in situ·breast neoplasm·angiosarcoma·breast cancer·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • Vol. 37, Issue 8 • 2019
PMID: 30676859DOI: 10.1200/JCO.18.00307

CYP2D6 and Endoxifen in Tamoxifen Therapy: A Tribute to David A. Flockhart.

Clinical pharmacology and therapeutics • Vol. 103, Issue 5 • 2018
PMID: 29473149DOI: 10.1002/cpt.1039

The Cytochrome P450 Enzyme Responsible for the Production of (Z)-Norendoxifen in vitro.

Chemistry & biodiversity • Vol. 15, Issue 1 • 2018
PMID: 28834279DOI: 10.1002/cbdv.201700287

Tamoxifen a pioneering drug: An update on the therapeutic potential of tamoxifen derivatives.

European journal of medicinal chemistry • Vol. 143 • 2018
PMID: 29207335DOI: 10.1016/j.ejmech.2017.11.056

Documentation

Similar Products